Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Clinical trial NCT01167426 · COMPLETED

Trial details

NCT number: NCT01167426
Sponsor: Teva Neuroscience, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2010-07-01
Primary completion: 2010-11-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.